Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Fulminant type 1 diabetes is a recently recognized diabetes subtype characterized by extremely rapid destruction of the pancreatic beta cells, leading to an absolute deficiency in insulin secretion. Fulminant type 1 diabetes is clinically characterized by the drastic onset of hyperglycemia and ketoacidosis within a few days, as well as near-normal glycated hemoglobin (HbA 1c ) levels despite remarkable hyperglycemia at initial presentation. A 41-year-old woman diagnosed with fulminant type 1 diabetes underwent 68 Ga-FAPI PET/CT, which showed intense FAPI uptake throughout the pancreas, especially in the pancreatic tail. Contrast-enhanced abdominal CT failed to reveal any pancreatic abnormalities. This case indicated that 68 Ga-FAPI PET/CT might be useful for evaluating patients with fulminant type 1 diabetes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/RLU.0000000000004684 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hepatitis A-Induced Fulminant Hepatic Failure Linked to Autoimmune Hepatitis in a Child Amidst Diagnostic Challenges of Dengue and Malaria.
Cureus
August 2025
Paediatrics, Farooq Hospital, West Wood Branch, Lahore, Lahore, PAK.
Hepatitis A virus (HAV) typically causes a self-limiting illness in children. Rarely, it can progress to fulminant hepatic failure (FHF), and even less commonly, may be followed by features suggestive of autoimmune hepatitis (AIH). The diagnostic overlap can be particularly challenging in tropical regions, where endemic infections such as dengue and malaria may present with similar clinical features.
View Article and Find Full Text PDF[Clinical characteristics of 24 cases of immune checkpoint inhibitors-induced type 1 diabetes].
Zhonghua Nei Ke Za Zhi
September 2025
Department of Geriatrics, People's Hospital of Henan Provincial, Zhengzhou 450003, China.
To analyze the clinical characteristics of immune checkpoint inhibitor (ICI)-induced type 1 diabetes (T1D). This was a retrospective case series study of clinical data from 24 patients with ICI-T1D admitted to People's Hospital of Henan Provincial between January 2018 and December 2024. The data collected included demographic characteristics, ICI usage, clinical manifestations, laboratory test results, and clinical outcome.
View Article and Find Full Text PDFCase Report: SARS-CoV-2-associated immune dysfunction manifesting as concurrent fulminant type 1 diabetes mellitus and subacute thyroiditis.
Front Med (Lausanne)
August 2025
Department of Endocrinology, Chengdu Shuangliu Hospital of Traditional Chinese Medicine, Chengdu, China.
Objectives: The association between SARS-CoV-2 infection and endocrine emergencies (such as fulminant type 1 diabetes mellitus and subacute thyroiditis) has received increasing attention. However, concurrent manifestations of these two conditions within a short period of time after infection are exceedingly rare, and the underlying mechanisms and clinical management strategies remain unclear.
Case Presentation: A 45-year-old Chinese man developed sudden polydipsia, polyuria, and cervical pain on day 7, within 2 weeks of SARS-CoV-2 infection.
A Case of Fulminant Type 1 Diabetes Induced by Immune Checkpoint Inhibitors in a Patient with Autoimmune Predisposition.
Intern Med
August 2025
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
We report a case of fulminant type 1 diabetes in a 73-year-old woman who was treated with nivolumab and ipilimumab for plantar malignant melanoma. Despite carrying the protective HLA-DRB1*15:01-DQB1*06:02 haplotype, she developed marked hyperglycemia (596 mg/dL), ketoacidosis, anti-GAD antibody positivity, HbA1c 6.6%, and low urinary C-peptide (1.
View Article and Find Full Text PDFLiver Transplantation in Childhood: A 2-Year Single Center Experience.
Transplant Proc
August 2025
Florya VM Medical Park Application and Research Hospital, Organ Transplantation Center, Dr. Istanbul Aydın University, Istanbul, Turkey.
Objective: Liver transplantation is currently the most treatment for fulminant hepatitis, end-stage liver failure, hepatocellular carcinoma, and liver-originated metabolic diseases in children. With technological advances, improvements in surgical techniques and immunosuppressive therapy protocols have increased 1-year survival rates to 80%-90%. Our center successfully performs both living donor and cadaveric liver transplants in children.
View Article and Find Full Text PDF